Neurothera Labs Inc. (TSXV:NTLX)

Neurothera Labs Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun 2, 2026	Dec 31, 2025	Dec 31, 2024
Market Capitalization	15	14	2
Market Cap Growth	-	537.22%	-
Enterprise Value	15	14	-
Last Close Price	0.18	0.17	0.15
PS Ratio	13.02	12.30	1.21
PB Ratio	17.20	16.24	1.02
EV/Sales Ratio	12.73	12.21	-
Debt / Equity Ratio	1.44	1.44	-
Net Debt / Equity Ratio	-1.18	-1.18	-0.08
Net Debt / EBITDA Ratio	0.30	0.30	0.05
Asset Turnover	0.36	0.36	-
Inventory Turnover	2.39	2.39	-
Quick Ratio	1.29	1.29	0.72
Current Ratio	1.35	1.35	1.26
Return on Equity (ROE)	-399.18%	-399.18%	-
Return on Assets (ROA)	-71.32%	-71.32%	-
Return on Capital Employed (ROCE)	-165.40%	-165.40%	-182.40%
Earnings Yield	-36.99%	-39.17%	-186.89%
Buyback Yield / Dilution	-	-6.54%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error